QQ客服 官方微博 反馈留言

浏览/检索结果: 共3条，第1-3条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Detection of HLA-B*58: 01 with TaqMan assay and its association with allopurinol-induced sCADR 期刊论文 CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2015, 卷号: 53, 期号: 3 作者:  Zhang, Xinju;  Ma, Huili;  Hu, Chunying;  Yu, Bo;  Ma, Weizhe 收藏  |  浏览/下载：11/0  |  提交时间：2019/12/19 allopurinol  HLA-B*58:01  severe cutaneous adverse drug reactions   HLA-B*58:01 allele is associated with augmented risk for both mild and severe cutaneous adverse reactions induced by allopurinol in Han Chinese 期刊论文 PHARMACOGENOMICS, 2012, 卷号: 13, 期号: 10 作者:  Cao, Zhi Hao;  Wei, Zhi-yun;  Zhu, Qin-yuan;  Zhang, Jun-yu;  Yang, Lun 收藏  |  浏览/下载：9/0  |  提交时间：2019/12/19 allopurinol  cutaneous adverse drug reactions  Han Chinese  HLA-B*5801   Severe cutaneous adverse drug reaction to leflunomide: A report of two cases 期刊论文 CUTANEOUS AND OCULAR TOXICOLOGY, 2008, 卷号: 27, 期号: 1, 页码: 5-9 作者:  Jian, Xingdong;  Guo, Guangran;  Ruan, Yanjun;  Lin, Dawei;  Li, Xingfu 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/26 cutaneous reactions  leflunomide  primary Sjogren's syndrome  systemic  lupus erythematosus